Association between chronic pain and substance use
- PMID: 40595886
- PMCID: PMC12217847
- DOI: 10.1038/s41598-025-04888-3
Association between chronic pain and substance use
Abstract
Chronic pain is a significant global health problem that affects millions of people globally and in the US which can sometimes lead to unhealthy coping mechanisms such as substance use. This case-control study aimed to examine the relationship between chronic pain and substance use using data from the National Health and Nutrition Examination Study (NHANES). Descriptive analysis and logistic regression models were used to compare the odds of substance use in individuals according to a history of ongoing (≥ 6 weeks) or chronic pain (≥ 3 months). A total of 980 individuals were included in the analysis. Among them, 87.4% reported no substance use, 10.2% single substance use, and 2.3% polysubstance use. Compared with 19.33% of non-substance users, 23.36% of single substance users and 39.21% of polysubstance users reported current ongoing pain (p-value: 0.04). Examining the association between substance use and chronic pain revealed that polysubstance users had a significantly higher risk of having current or a history of ongoing pain or a history of chronic pain compared to non-users, with adjusted odds ratios (aORs) ranging from 2.28 (95% CI 2.27-2.29) to 6.30 (95% CI 6.28-6.32). Single substance users also faced increased risk, with aORs from 1.19 (95% CI 1.18-1.20) to 2.14 (95% CI 2.13-2.15). These results highlight the elevated risk of substance use associated with chronic pain, particularly elevated risk of polysubstance use, after adjustments for demographic, socioeconomic, and mental health factors. These findings emphasize the need for targeted interventions addressing chronic pain to potentially mitigate substance use risks.
Keywords: Chronic pain; Depression; Depressive symptoms; Polysubstance; Substance use.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Similar articles
-
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2. Cochrane Database Syst Rev. 2023. Update in: Cochrane Database Syst Rev. 2023 May 15;5:CD014908. doi: 10.1002/14651858.CD014908.pub3. PMID: 36622724 Free PMC article. Updated.
-
Sodium-glucose cotransporter 2 inhibitors and inverse risk of new-onset atopic dermatitis in a cohort with diabetes: a nationwide active-comparator study.Br J Dermatol. 2025 Jun 20;193(1):74-84. doi: 10.1093/bjd/ljaf086. Br J Dermatol. 2025. PMID: 40037684
-
The association between hearing loss and depression in the China health and retirement longitudinal study.Sci Rep. 2025 Jul 1;15(1):20537. doi: 10.1038/s41598-025-05749-9. Sci Rep. 2025. PMID: 40595946 Free PMC article.
-
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1. MMWR Surveill Summ. 2025. PMID: 40493548 Free PMC article.
-
Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD010204. doi: 10.1002/14651858.CD010204.pub2. Cochrane Database Syst Rev. 2016. PMID: 27040448 Free PMC article.
References
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical